Detalhe da pesquisa
1.
68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography Maximum Standardized Uptake Value as a Predictor of Gleason Pattern 4 and Pathological Upgrading in Intermediate-Risk Prostate Cancer.
J Urol
; 207(2): 341-349, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34546815
2.
Detection and localisation of primary prostate cancer using 68 gallium prostate-specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology.
BJU Int
; 126(1): 83-90, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31260602
3.
Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?
BJU Int
; 114(3): 384-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24612341
4.
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.
Eur Urol
; 84(1): 65-85, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37117107
5.
Combined Utility of 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Predicting Prostate Biopsy Pathology.
Eur Urol Oncol
; 5(3): 314-320, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741337
6.
Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Eur Urol Focus
; 8(3): 674-689, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33967010
7.
Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review.
Eur Urol Focus
; 8(3): 690-700, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34147405
8.
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.
Eur Urol
; 81(4): 337-346, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34980492
9.
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition.
Mol Cancer Ther
; 20(11): 2140-2150, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413130
10.
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer.
Eur Urol
; 80(5): 531-545, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33962808
11.
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.
Eur Urol Oncol
; 4(3): 405-423, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423943
12.
Transperineal prostate biopsy: template-guided or freehand?
BJU Int
; 115(5): 681-3, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25041087
13.
Can magnetic resonance imaging solve the prostate cancer conundrum?
Med J Aust
; 202(8): 410-1, 2015 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25929494
14.
Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations.
Eur Urol Focus
; 6(2): 231-234, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248850
15.
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
Eur Urol
; 77(5): 614-627, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32146018
16.
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
Eur Urol
; 75(6): 967-987, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30342843
17.
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).
Eur Urol
; 76(6): 790-813, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587989
18.
Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.
Eur Urol
; 73(3): 316-321, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29103760
19.
Effect of triptorelin on lower urinary tract symptoms in Australian prostate cancer patients.
Res Rep Urol
; 9: 27-35, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28261572
20.
TREXIT Is Now: Should We Abandon the Transrectal Route for Prostate Biopsy? Yes.
Eur Urol Open Sci
; 31: 14-16, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34467236